Lutetium-177 labeled girentuximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177 labeled girentuximab, covering 2015-08-13 to 2015-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer [Phase 2]